BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 11069486)

  • 1. Clinical profile of vitiligo patients and relationship with immuno-inflammatory markers.
    Mascarenhas MRM; Oliveira MC; Oliveira LF; Magalhães AS; Machado PRL
    An Bras Dermatol; 2024; 99(2):196-201. PubMed ID: 37985303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful Repigmentation of Vitiligo-Like Hypopigmentation in a Case of Acanthosis Nigricans.
    Chun SH; Park JH; Park JB; Kim IH
    Ann Dermatol; 2017 Apr; 29(2):256-258. PubMed ID: 28392666
    [No Abstract]   [Full Text] [Related]  

  • 3. Generalised acanthosis nigricans with vitiligo.
    Blume-Peytavi U; Spieker T; Reupke H; Orfanos CE
    Acta Derm Venereol; 1996 Sep; 76(5):377-80. PubMed ID: 8891012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HAIR-AN syndrome in a male adolescent with concomitant vitiligo.
    Shen Z; Hao F; Wei P
    Arch Dermatol; 2009 Apr; 145(4):492-4. PubMed ID: 19380681
    [No Abstract]   [Full Text] [Related]  

  • 5. Acanthosis nigricans and insulin resistance associated with hypothyroidism.
    Ober KP
    Arch Dermatol; 1985 Feb; 121(2):229-31. PubMed ID: 3977337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance and acanthosis nigricans. Report of a case with antibodies to insulin receptors.
    Pulini M; Raff SB; Chase R; Gordon EE
    Ann Intern Med; 1976 Dec; 85(6):749-51. PubMed ID: 1087135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of insulin resistance in obese women with and without acanthosis nigricans.
    Sadeghian G; Ziaie H; Amini M; Ali Nilfroushzadeh M
    J Dermatol; 2009 Apr; 36(4):209-12. PubMed ID: 19348659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acanthosis nigricans with vitiligo and insulin resistance.
    Harman M; Akdeniz S; Cetin H; Tuzcu A
    Br J Dermatol; 2000 Oct; 143(4):899-900. PubMed ID: 11069486
    [No Abstract]   [Full Text] [Related]  

  • 9. Acanthosis nigricans associated with insulin resistance : pathophysiology and management.
    Hermanns-Lê T; Scheen A; Piérard GE
    Am J Clin Dermatol; 2004; 5(3):199-203. PubMed ID: 15186199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous stigmata associated with insulin resistance and increased cardiovascular risk.
    Schilling WH; Crook MA
    Int J Dermatol; 2014 Sep; 53(9):1062-9. PubMed ID: 24697530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic insulin resistance].
    Field JB
    Acta Diabetol Lat; 1970; 7(2):220-42. PubMed ID: 5533173
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic and Autoimmune Diseases.
    Delgadillo X; Ortega AE; Greco AM
    Clin Colon Rectal Surg; 2019 Sep; 32(5):372-376. PubMed ID: 31507347
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.